These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 13216816)
1. Observations on the nature of the neuromuscular block in myasthenia gravis. HARVEY AM; GROB D; JOHNS RJ Trans Assoc Am Physicians; 1954; 67():94-6. PubMed ID: 13216816 [No Abstract] [Full Text] [Related]
2. Neuromuscular transmission with a note on myasthenia gravis. MEAD JC McGill Med J; 1957 Apr; 26(2):88-95. PubMed ID: 13429923 [No Abstract] [Full Text] [Related]
3. An electrophysiologic study of the neuromuscular junction in myasthenia gravis. DAHLBACK O; ELMQVIST D; JOHNS TR; RADNER S; THESLEFF S J Physiol; 1961 Apr; 156(2):336-43. PubMed ID: 13719322 [No Abstract] [Full Text] [Related]
4. Studies in neuromuscular function. II. Effects of nerve stimulation in normal subjects and in patients with myasthenia gravis. GROB D; HARVEY AM; JOHNS RJ Bull Johns Hopkins Hosp; 1956 Sep; 99(3):125-35. PubMed ID: 13364528 [No Abstract] [Full Text] [Related]
5. Motor end plate changes in myasthenia gravis. CHURCHILL-DAVIDSON HC Am J Phys Med; 1959 Aug; 38():159-62. PubMed ID: 13810230 [No Abstract] [Full Text] [Related]
7. Observations on the nature of the neuromuscular block in myasthenia gravis. GROB D; JOHNS RJ; HARVEY AM Trans Assoc Am Physicians; 1955; 68():50-3. PubMed ID: 13299310 [No Abstract] [Full Text] [Related]
8. [Pathogenic investigations on myasthenia and myotonia with special reference to therapy. II. Effect of blood serum isolated in myotonia on nerve-muscle preparation in frog]. KURES H; MALEK P Cas Lek Cesk; 1952 Jun; 91(24-25):709-11. PubMed ID: 14390261 [No Abstract] [Full Text] [Related]
9. Myasthenia gravis. III. Lack of inhibitory action of fractionated thymus extracts. ZACKS SI Proc Soc Exp Biol Med; 1958 Dec; 99(3):574-5. PubMed ID: 13614427 [No Abstract] [Full Text] [Related]
10. [Pathogenesis of partial neuromuscular block in experimental myasthenia gravis]. Kalden JR Verh Dtsch Ges Inn Med; 1973; 79():588-9. PubMed ID: 4790302 [No Abstract] [Full Text] [Related]
11. Delayed increase of neuromuscular block in a series of faradizations of the motor nerve in myasthenic patients. DESMEDT JE J Physiol; 1958 Jan; 140(1):3-4P. PubMed ID: 13514660 [No Abstract] [Full Text] [Related]
13. Neuromuscular transmission in myasthenia gravis. CHURCHILL-DAVIDSON HC; RICHARDSON AT Am J Med; 1955 Nov; 19(5):691-2. PubMed ID: 13268465 [No Abstract] [Full Text] [Related]
14. Neuromuscular pharmacology. Karczmar AG Annu Rev Pharmacol; 1967; 7():241-76. PubMed ID: 5337082 [No Abstract] [Full Text] [Related]
15. Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis. Gehi A; Benatar M; Langberg J J Cardiovasc Electrophysiol; 2008 Feb; 19(2):214-6. PubMed ID: 17711430 [TBL] [Abstract][Full Text] [Related]
16. Alterations in neuromuscular transmission in myasthenia gravis as determined by studies of drug action. GROB D; JOHNS RJ; HARVEY AM Am J Med; 1955 Nov; 19(5):684-90. PubMed ID: 13268464 [No Abstract] [Full Text] [Related]
17. Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in Myasthenia Gravis patients. Rostedt A; Padua L; Stålberg EV Clin Neurophysiol; 2005 Sep; 116(9):2058-64. PubMed ID: 16043394 [TBL] [Abstract][Full Text] [Related]